BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

632 related articles for article (PubMed ID: 22392529)

  • 1. Decision making in advanced heart failure: a scientific statement from the American Heart Association.
    Allen LA; Stevenson LW; Grady KL; Goldstein NE; Matlock DD; Arnold RM; Cook NR; Felker GM; Francis GS; Hauptman PJ; Havranek EP; Krumholz HM; Mancini D; Riegel B; Spertus JA; ; ; ; ; ;
    Circulation; 2012 Apr; 125(15):1928-52. PubMed ID: 22392529
    [No Abstract]   [Full Text] [Related]  

  • 2. ACCF/HRS/AHA/ASE/HFSA/SCAI/SCCT/SCMR 2013 appropriate use criteria for implantable cardioverter-defibrillators and cardiac resynchronization therapy: a report of the American College of Cardiology Foundation appropriate use criteria task force, Heart Rhythm Society, American Heart Association, American Society of Echocardiography, Heart Failure Society of America, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance.
    Russo AM; Stainback RF; Bailey SR; Epstein AE; Heidenreich PA; Jessup M; Kapa S; Kremers MS; Lindsay BD; Stevenson LW
    Heart Rhythm; 2013 Apr; 10(4):e11-58. PubMed ID: 23473952
    [No Abstract]   [Full Text] [Related]  

  • 3. State of the science: promoting self-care in persons with heart failure: a scientific statement from the American Heart Association.
    Riegel B; Moser DK; Anker SD; Appel LJ; Dunbar SB; Grady KL; Gurvitz MZ; Havranek EP; Lee CS; Lindenfeld J; Peterson PN; Pressler SJ; Schocken DD; Whellan DJ; ; ; ; ;
    Circulation; 2009 Sep; 120(12):1141-63. PubMed ID: 19720935
    [No Abstract]   [Full Text] [Related]  

  • 4. [Prevention of sudden death in heart failure patients: cardiac resynchronization therapy with or without defibrillation back-up].
    Pedretti RF; Laporta A; Masnaghetti S; Raimondo R; Salerno M; Santoro F; Vaninetti R
    G Ital Cardiol (Rome); 2010 Oct; 11(10 Suppl 1):134S-136S. PubMed ID: 21416844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The heart failure paradox: an epidemic of scientific success. Presidential Address at the American Heart Association 2013 Scientific Sessions.
    Jessup M
    Circulation; 2014 Jun; 129(25):2717-22. PubMed ID: 24958756
    [No Abstract]   [Full Text] [Related]  

  • 6. Informed consent in cardiac resynchronization therapy: what should be said?
    Kramer DB; Brock DW; Tedrow UB
    Circ Cardiovasc Qual Outcomes; 2011 Sep; 4(5):573-7. PubMed ID: 21934080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimisation of cardiac resynchronisation therapy device selection guided by cardiac magnetic resonance imaging: Cost-effectiveness analysis.
    Crespo C; Linhart M; Acosta J; Soto-Iglesias D; Martínez M; Jáuregui B; Mira Á; Restovic G; Sagarra J; Auricchio A; Fahn B; Boltyenkov A; Lasalvia L; Sampietro-Colom L; Berruezo A
    Eur J Prev Cardiol; 2020 Apr; 27(6):622-632. PubMed ID: 31487998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The Relationship Between Quality of Life and Psychological and Behavioral Factors in Patients With Heart Failure Following Cardiac Resynchronization Therapy].
    Huang J; Fang JB; Zhao YH
    Hu Li Za Zhi; 2018 Jun; 65(3):58-70. PubMed ID: 29790140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac resynchronization for New York Heart Association class IV patients.
    Geng J; Zhu J
    Europace; 2010 Dec; 12(12):1797; author reply 1797-8. PubMed ID: 20876275
    [No Abstract]   [Full Text] [Related]  

  • 10. Exploring the Importance of Health Literacy for the Quality of Life in Patients with Heart Failure.
    Jovanić M; Zdravković M; Stanisavljević D; Jović Vraneš A
    Int J Environ Res Public Health; 2018 Aug; 15(8):. PubMed ID: 30115831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heart failure management in skilled nursing facilities: a scientific statement from the American Heart Association and the Heart Failure Society of America.
    Jurgens CY; Goodlin S; Dolansky M; Ahmed A; Fonarow GC; Boxer R; Arena R; Blank L; Buck HG; Cranmer K; Fleg JL; Lampert RJ; Lennie TA; Lindenfeld J; Piña IL; Semla TP; Trebbien P; Rich MW; ;
    J Card Fail; 2015 Apr; 21(4):263-99. PubMed ID: 25863664
    [No Abstract]   [Full Text] [Related]  

  • 12. Advanced heart failure: Where do we stand?
    Tousoulis D
    Hellenic J Cardiol; 2018; 59(6):303-305. PubMed ID: 30853606
    [No Abstract]   [Full Text] [Related]  

  • 13. Resynchronization therapy in heart failure: the 'nonresponder'.
    Sinagra G; Proclemer A; Zecchin M
    J Cardiovasc Med (Hagerstown); 2018 Feb; 19 Suppl 1():e112-e115. PubMed ID: 29538157
    [No Abstract]   [Full Text] [Related]  

  • 14. Role of Biomarkers for the Prevention, Assessment, and Management of Heart Failure: A Scientific Statement From the American Heart Association.
    Chow SL; Maisel AS; Anand I; Bozkurt B; de Boer RA; Felker GM; Fonarow GC; Greenberg B; Januzzi JL; Kiernan MS; Liu PP; Wang TJ; Yancy CW; Zile MR;
    Circulation; 2017 May; 135(22):e1054-e1091. PubMed ID: 28446515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [CRT, clinical benefit and quality of life: together or separately?].
    Oręziak A
    Kardiol Pol; 2012; 70(6):589-90. PubMed ID: 22718377
    [No Abstract]   [Full Text] [Related]  

  • 16. Chronic Heart Failure in Congenital Heart Disease: A Scientific Statement From the American Heart Association.
    Stout KK; Broberg CS; Book WM; Cecchin F; Chen JM; Dimopoulos K; Everitt MD; Gatzoulis M; Harris L; Hsu DT; Kuvin JT; Law Y; Martin CM; Murphy AM; Ross HJ; Singh G; Spray TL;
    Circulation; 2016 Feb; 133(8):770-801. PubMed ID: 26787728
    [No Abstract]   [Full Text] [Related]  

  • 17. 2017 ACC/AHA/HFSA/ISHLT/ACP Advanced Training Statement on Advanced Heart Failure and Transplant Cardiology (Revision of the ACCF/AHA/ACP/HFSA/ISHLT 2010 Clinical Competence Statement on Management of Patients With Advanced Heart Failure and Cardiac Transplant): A Report of the ACC Competency Management Committee.
    Jessup M; Drazner MH; Book W; Cleveland JC; Dauber I; Farkas S; Ginwalla M; Katz JN; Kirkwood P; Kittleson MM; Marine JE; Mather P; Morris AA; Polk DM; Sakr A; Schlendorf KH; Vorovich EE
    Circ Heart Fail; 2017 Jun; 10(6):. PubMed ID: 28607153
    [No Abstract]   [Full Text] [Related]  

  • 18. Recommendations for the Use of Mechanical Circulatory Support: Ambulatory and Community Patient Care: A Scientific Statement From the American Heart Association.
    Cook JL; Colvin M; Francis GS; Grady KL; Hoffman TM; Jessup M; John R; Kiernan MS; Mitchell JE; Pagani FD; Petty M; Ravichandran P; Rogers JG; Semigran MJ; Toole JM;
    Circulation; 2017 Jun; 135(25):e1145-e1158. PubMed ID: 28559233
    [No Abstract]   [Full Text] [Related]  

  • 19. Usefulness of the CRT-SCORE for Shared Decision Making in Cardiac Resynchronization Therapy in Patients With a Left Ventricular Ejection Fraction of ≤35.
    Höke U; Mertens B; Khidir MJH; Schalij MJ; Bax JJ; Delgado V; Ajmone Marsan N
    Am J Cardiol; 2017 Dec; 120(11):2008-2016. PubMed ID: 29031415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Device therapy in heart failure].
    Kozhuharov N; Sticherling C; Schär B
    Ther Umsch; 2018 Sep; 75(3):187-192. PubMed ID: 30145977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.